Government's incentive system for medical institution's low-priced drug purchase sparks criticism

Published: 2003-09-15 07:00:00

Updated: 2003-09-15 07:00:00

As the Ministry of Health and Welfare and the Korea Hospitals Association are reportedly moving toward the introduction of a new incentive system for medical institution's low-priced drug purchase as part of reforming drug-related administration, domestic pharmaceutical industry opposes the gover...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK